• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD (SUZHOU) BD INTIMA-II CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD (SUZHOU) BD INTIMA-II CLOSED IV CATHETER SYSTEM; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383033
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Extravasation (1842); Pain (1994); Swelling (2091)
Event Date 10/22/2020
Event Type  Injury  
Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that the bd intima-ii¿ closed iv catheter system caused extravasation in the patient, and a "magnesium sulfate wet hot compress" was used on the "red parts" of the patient's affected area.The following information was provided by the initial reporter, translated from (b)(6) to english: "on (b)(6), 2020 patients with coronary heart disease (chd) in undergraduate course, in no.20002087 , because of illness need to closed venous indwelling needle puncture infusion, at 15:12 the patient reported redness, swelling and pain around the indwelling needle, nurse examined and revealed needle push drug resistance, fluid extravasation, pull, prescribed for red parts of magnesium sulfate wet hot compress, change the body to continue to infusion.The patient's transfusion was normal.On (b)(6), the patient's coronary heart disease improved and left the hospital, and the limbs partially returned to normal.".
 
Manufacturer Narrative
H.6.Investigation: a device history review was conducted for lot number 0063924.Our records show that this is the only instance of this issue occurring in this production batch.According to the sampling plan applied for product performance, this lot was accepted and released without defects being noted during the final assembly or visual inspections.A sample could not be obtained for evaluation and testing; in lieu of the affected device, functional testing was performed on retention samples for this lot, the results of these show that the tested units performed within product specifications.Unfortunately without the ability to investigate the affected unit our quality engineers were unable to determine the root cause for this the reported functional non-conformance.Additionally, this lot was treated and received a certificate of conformance for sterility.H3 other text : see h.10.
 
Event Description
It was reported that the bd intima-ii¿ closed iv catheter system caused extravasation in the patient, and a "magnesium sulfate wet hot compress" was used on the "red parts" of the patient's affected area.The following information was provided by the initial reporter, translated from chinese to english: "on (b)(6) 2020 patients with coronary heart disease (chd) in undergraduate course, in no.(b)(4), because of illness need to closed venous indwelling needle puncture infusion, at 15:12 the patient reported redness, swelling and pain around the indwelling needle, nurse examined and revealed needle push drug resistance, fluid extravasation, pull, prescribed for red parts of magnesium sulfate wet hot compress, change the body to continue to infusion.The patient's transfusion was normal.On (b)(6), the patient's coronary heart disease improved and left the hospital, and the limbs partially returned to normal.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INTIMA-II CLOSED IV CATHETER SYSTEM
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD (SUZHOU)
no. 5 baiyu road
suzhou industrial park
suzhou
MDR Report Key10939341
MDR Text Key219321745
Report Number3006948883-2020-00881
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 01/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/30/2023
Device Catalogue Number383033
Device Lot Number0063924
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/06/2020
Initial Date FDA Received12/03/2020
Supplement Dates Manufacturer Received01/27/2021
Supplement Dates FDA Received01/31/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-